Citation: B. Glinski et al., ALTERED THERAPY SCHEDULES IN POSTOPERATIVE TREATMENT OF PATIENTS WITHMALIGNANT GLIOMAS - 20 YEAR EXPERIENCE OF THE MARIA-SKLODOWSKA-CURIE-MEMORIAL-CENTER IN KRAKOW, 1973-1993, Journal of neuro-oncology, 36(2), 1998, pp. 159-165
Authors:
RILEY MGI
KIM NN
WATSON VE
GOBIN YP
LEBEL CP
BLACK KL
BARTUS RT
Citation: Mgi. Riley et al., INTRAARTERIAL ADMINISTRATION OF CARBOPLATIN AND THE BLOOD-BRAIN-BARRIER PERMEABILIZING AGENT, RMP-7 - A TOXICOLOGIC EVALUATION IN SWINE, Journal of neuro-oncology, 36(2), 1998, pp. 167-178
Authors:
BRANDES A
CAROLLO C
GARDIMAN M
SCELZI E
BOTTIN R
ZAMPIERI P
RIGON A
FIORENTINO MV
Citation: A. Brandes et al., UNUSUAL NASAL AND ORBITAL INVOLVEMENT OF GLIOBLASTOMA-MULTIFORME - A CASE-REPORT AND REVIEW OF THE LITERATURE, Journal of neuro-oncology, 36(2), 1998, pp. 179-183
Authors:
DROPCHO EJ
ROSENFELD SS
VITEK J
GUTHRIE BL
MORAWETZ RB
Citation: Ej. Dropcho et al., PHASE-II STUDY OF INTRACAROTID OR SELECTIVE INTRACEREBRAL INFUSION OFCISPLATIN FOR TREATMENT OF RECURRENT ANAPLASTIC GLIOMAS, Journal of neuro-oncology, 36(2), 1998, pp. 191-198
Citation: Cm. Hand et al., CHEMOTHERAPY IN EXPERIMENTAL BRAIN-TUMOR, PART 1 - IN-VITRO COLORIMETRIC MTT ASSAY, Journal of neuro-oncology, 36(1), 1998, pp. 1-6
Citation: P. Black et al., CHEMOTHERAPY IN EXPERIMENTAL BRAIN-TUMOR, PART 2 - PRETREATMENT WITH LEUKOTRIENE C-4 PROLONGS SURVIVAL, Journal of neuro-oncology, 36(1), 1998, pp. 7-19
Authors:
FORSYTH PA
LAING TD
GIBSON AW
REWCASTLE NB
BRASHER P
SUTHERLAND G
JOHNSTON RN
EDWARDS DR
Citation: Pa. Forsyth et al., HIGH-LEVELS OF GELATINASE-B AND ACTIVE GELATINASE-A IN METASTATIC GLIOBLASTOMA, Journal of neuro-oncology, 36(1), 1998, pp. 21-29
Authors:
TREDICI G
TREDICI S
FABBRICA D
MINOIA C
CAVALETTI G
Citation: G. Tredici et al., EXPERIMENTAL CISPLATIN NEURONOPATHY IN RATS AND THE EFFECT OF RETINOIC ACID ADMINISTRATION, Journal of neuro-oncology, 36(1), 1998, pp. 31-40
Authors:
TAKI T
OHNISHI T
ARITA N
HIRAGA S
HAYAKAWA T
Citation: T. Taki et al., IN-VIVO ETOPOSIDE-RESISTANT C6 GLIOMA CELL-LINE - SIGNIFICANCE OF ALTERED DNA TOPOISOMERASE-II ACTIVITY IN MULTIDRUG-RESISTANCE, Journal of neuro-oncology, 36(1), 1998, pp. 41-53
Citation: Jm. Gomori et al., LEPTOMENINGEAL METASTASES - EVALUATION BY GADOLINIUM-ENHANCED SPINAL MAGNETIC-RESONANCE-IMAGING, Journal of neuro-oncology, 36(1), 1998, pp. 55-60
Authors:
BUCKNER JC
BURCH PA
CASCINO TL
OFALLON JR
SCHEITHAUER BW
Citation: Jc. Buckner et al., PHASE-II TRIAL OF RECOMBINANT INTERFERON-ALPHA-2A AND EFLORNITHINE INPATIENTS WITH RECURRENT GLIOMA, Journal of neuro-oncology, 36(1), 1998, pp. 65-70
Authors:
HSIUNG CY
LEUNG SW
WANG CJ
LO SK
CHEN HC
SUN LM
FANG FM
Citation: Cy. Hsiung et al., THE PROGNOSTIC FACTORS OF LUNG-CANCER PATIENTS WITH BRAIN METASTASES TREATED WITH RADIOTHERAPY, Journal of neuro-oncology, 36(1), 1998, pp. 71-77
Authors:
SALAME K
MERIMSKY O
YOSIPOV J
REIDERGROSWASSER I
CHAITCHIK S
OUAKNINE GE
Citation: K. Salame et al., PRIMARY INTRAMEDULLARY SPINAL MELANOMA - DIAGNOSTIC AND TREATMENT PROBLEMS, Journal of neuro-oncology, 36(1), 1998, pp. 79-83
Citation: Pm. Black et M. Westphal, PREFACE - GROWTH-FACTORS, GLIAL-CELLS AND NEUROONCOLOGY - PERSPECTIVES FOR TREATMENT, Journal of neuro-oncology, 35(3), 1997, pp. 189-190
Citation: Mm. Feldkamp et al., SIGNAL-TRANSDUCTION PATHWAYS AND THEIR RELEVANCE IN HUMAN ASTROCYTOMAS, Journal of neuro-oncology, 35(3), 1997, pp. 223-248
Citation: Dm. Ashley et al., MONOCLONAL-ANTIBODIES TO GROWTH-FACTORS AND GROWTH-FACTOR RECEPTORS -THEIR DIAGNOSTIC AND THERAPEUTIC POTENTIAL IN BRAIN-TUMORS, Journal of neuro-oncology, 35(3), 1997, pp. 259-273
Citation: Jw. Campbell et If. Pollack, GROWTH-FACTORS IN GLIOMAS - ANTISENSE AND DOMINANT-NEGATIVE MUTANT STRATEGIES, Journal of neuro-oncology, 35(3), 1997, pp. 275-285